PAGB recruits Riddalls as senior director

PAGB recruits Riddalls as senior director
Michelle Riddalls has worked for Pfizer Consumer Healthcare and Johnson & Johnson

24 May 2019 - Deborah Wilkes

The Proprietary Association of Great Britain (PAGB) has appointed Michelle Riddalls as senior director of regulatory affairs and advertising services.

Chief executive John Smith said Riddalls was a "leading expert in consumer healthcare regulation".

Up until March 2019, Riddalls worked for Pfizer Consumer Healthcare as director, regulatory affairs, country cluster lead Northern Europe. She has also worked for Johnson & Johnson.

During her time at Pfizer Consumer Healthcare, Riddalls worked on the switch of Nexium Control (esomeprazole) from prescription to general-sale list status in the UK as well as the switch of Viagra Connect (sildenafil) from prescription to pharmacy status in the UK.

At the PAGB, Riddalls will be responsible for the regulatory and advertising services functions, including copy clearance.

Smith said her knowledge and experience would be "hugely valuable" and would ensure the industry association continued to provide a "world-class service to its member companies across OTC medicines, self-care medical devices and food supplements".

Castle promoted to senior director

Riddalls joins the PAGB on 3 June 2019. At the same time, Donna Castle will be promoted to senior director of public affairs and communications. Castle is currently director of public affairs and communications.

The PAGB said the changes were part of a management restructuring designed to ensure it had the "right leadership to deliver its objectives and take forward its new strategy to 2025".

Take out an Annual Subscription to the OTCToolbox website, giving you UNLIMITED ACCESS to all of our publications
* Premium News Stories
* OTCToolbox Innovations magazine NEW IDEAS BETTER WAYS
* OTCToolbox Deals Database
* News Extras
* OTC Deal Trends Briefing
* OTC Company Strategies Report
Helping you and your company make well-informed decisions
CLICK HERE TO FIND OUT MORE

Click tags below for more information on topics:

Pfizer

Back to Industry News

Share this page: